You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • THU0363 Impact of adalimumab on clinical outcomes, healthcare resource utilization and sick leaves in ankylosing spondylitis patients in central and eastern europe

Citation Tools

Article menu

Download PDFPDF

Poster Presentations
Spondyloarthritis - treatment
THU0363 Impact of adalimumab on clinical outcomes, healthcare resource utilization and sick leaves in ankylosing spondylitis patients in central and eastern europe
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Opris-Belinski D, Erdes S, Grazio S, et al
THU0363 Impact of adalimumab on clinical outcomes, healthcare resource utilization and sick leaves in ankylosing spondylitis patients in central and eastern europe
Annals of the Rheumatic Diseases 2017;76:342-343.